Longevity Health Holdings Merges With Thplasma, Ends 20/20 Biolabs Deal
Longevity Health Holdings (Nasdaq: XAGE), a company focused on longevity and healthy aging, is merging with True Health Inc....
Sanara MedTech Launches Tissue Health Plus Wound Care Pilot Program
Sanara MedTech has launched a pilot program for its Tissue Health Plus (THP) wound care platform, targeting value-based care...
Leadership Transition & Merger Creates $40M Addiction Therapeutics Powerhouse
Branded Legacy Inc. is undergoing a rapid transformation, shifting its focus from plant-based wellness and cannabis beverages to the...
23andMe Assets Acquired by Ttam Research Institute
Ttam Research Institute, a non-profit led by Anne Wojcicki, has finalized its acquisition of 23andMe’s personal genome service and...
Borvo Evac™ System Demonstrates 100% Success in Chronic Subdural Hematoma Cases
Borvo Medical’s Evac System Achieves 100% Success Rate in Initial Chronic Subdural Hematoma Cases Borvo Medical’s newly FDA-cleared Evac...
Emrosi™ Expands Payer Coverage
Journey Medical Corporation has significantly expanded payer coverage for its recently launched rosacea treatment, emrosi™ (minocycline hydrochloride modified-release capsules)....
Salarius Pharmaceuticals Granted Nasdaq Extension
Salarius Pharmaceuticals has received another extension from Nasdaq, pushing the deadline for regaining compliance with minimum bid price and...
Amtagvi® Shows 49% Response Rate in Advanced Melanoma Patients
Iovance Biotherapeutics’ real-world data reinforces the clinical value of Lifileucel (amtagvi) in advanced melanoma. The recently released data from...
Immix Biopharma Shows Class-Leading Safety, Eyes Future Expansion
Immix Biopharma announced promising safety data for its sterically-optimized CAR-T cell therapy, NXC-201, in patients with AL amyloidosis, notably...
Variational AI Wins Emerging Biotech Company of the Year
Rakovina Therapeutics’ partner, Variational AI, has been awarded the 2025 Emerging Company of the Year – Biotech by Life...